Clinical Trial: An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease

U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07724132) titled 'An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease' on Sept. 11, 2025.

Brief Summary: A multicentre, interventional, multi-arm, multi-stage Phase 3 trial including randomisation, double blinding, placebo control evaluation of treatments for sustained clinical response (18 months) in symptomatic Alzheimer's Disease in a population representative of people with Alzheimer's disease in the UK.

Study Start Date: July 24

Study Type: INTERVENTIONAL

Condition: Alzheimer's Disease (AD) Mild Cognitive Impairment Due to Alzheimer's Disease Alzheimer Disease Dementia

Intervention:...